Post by Ajinomoto Bio-Pharma Services
19,220 followers
Explore where innovation meets impact. At our Kawasaki R&D facility, CORYNEX® is enabling the next generation of biologics. From long-chain peptides to antibody mimetics and VHHs, our microbial expression platform enables efficient, scalable production with high purity and simplified downstream processing. Heading to CPHI Japan? Connect with our team to learn more: https://bit.ly/4tj1ua3
Video Content